41
Manfred Franetzki, Klaus Gagneur, Karl Prestele: Device for the pre-programmable infusion of liquids. Siemens Aktiengesellschaft, Hill Van Santen Steadman Chiara & Simpson, August 11, 1981: US04282872 (254 worldwide citation)

Particularly for diabetes therapy, it is desirable to continuously infuse insulin in different rates into the body of the patient, because the insulin requirements of the diabetic are subject to great fluctuations. Therefore, a control device serves as the program transmitter for a microdosing unit. ...


42
Robert S Galen, John F Burd, Talei Hoblitzell, Gebhard Neyer: Combined assay for current glucose level and intermediate or long-term glycemic control. LXN, Campbell & Flores, December 9, 1997: US05695949 (250 worldwide citation)

The present invention is directed to a single test system and method for determining the integrated glycemic condition of a subject by measuring the concentration of glucose and the level of protein-bound glucose in a subject's body fluid, such as whole blood. The glucose concentration is indicative ...


43
H Benjamin Diaz, M Inez Genera: Personalized hand held calorie computer (ECC). March 30, 1999: US05890128 (247 worldwide citation)

A novel hand held individually customized interactive integrated circuit device for nutrition and exercise management. Featuring built in Random Access Memory (RAM) Storage of extensive food lists with associated caloric and fat contents. The device also incorporates RAM storage of exercises with as ...


44
Jan Wojcicki, Boguslaw Lilpop, Marek Ziembicki, Stanislaw Bielawski: Device for monitoring the operation of a delivery system and the method of use thereof. Institute of Biocybernetics and Biomedical Engineering P, Novo Nordisk, Steve T Zelson, Elias J Lambiris, March 2, 1993: US05190522 (245 worldwide citation)

A device for monitoring a delivery system comprising a volumetric micropump, a measuring element or sensor located in the infusion line, a matching system and an analyzing system. The devices are preferably for use in insulin administration when treating type-I diabetes and in analytical laboratorie ...


45
Elizabeth A Cummings, Mary E McEvoy, Lars H Berger, Ulrich Kraft, Rainer R Teucher, John C Davis: Analyte testing device. Diabetes Diagnostics, Bernard E Shay, July 10, 2007: US07241265 (243 worldwide citation)

The present invention is a testing device for testing analyte levels in bodily fluids. The testing device comprises memory (202) for storing data, said data being analyte data related to analyte measurements carried out by the meter and lifestyle data; initiation means (102) for initiating immediate ...


46
John Eng: Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same. Allegretti & Witcoff, June 13, 1995: US05424286 (243 worldwide citation)

This invention encompasses pharmaceutical compositions containing exendin-3 or exendin-4, fragments thereof, or any combination thereof, and methods for the treatment of diabetes mellitus and the prevention of hyperglycemia.


47
Peyser Thomas A, Taub Marc B, Stafford Gary Ashley, Hoss Udo, Morgan Roy E, Lee Daniel H, Mazza John C, Naegeli Andrew H: Medical device insertion. Abbott Diabetes Care, Peyser Thomas A, Taub Marc B, Stafford Gary Ashley, Hoss Udo, Morgan Roy, E, Lee Daniel, H, Mazza John C, Naegeli Andrew H, OH Kuni, October 25, 2007: WO/2007/120363 (243 worldwide citation)

Devices and methods for inserting at least a portion of a medical device in a patient are provided. Embodiments include medical device insertions that employ a plurality of insertion stages. Also provided are systems and kits for use in analyte monitoring.


48
Douglas I Buckley, Joel F Habener, Joanne B Mallory, Svetlana Mojsov: GLP-1 analogs useful for diabetes treatment. Morrison & Foerster, August 13, 1996: US05545618 (241 worldwide citation)

The invention provides effective analogs of the active GLP-1 peptides, 7-34, 7-35, 7-36, and 7-37, which have improved characteristics for treatment of diabetes Type II. These analogs have amino acid substitutions at positions 7-10 and/or are truncated at the C-terminus and/or contain various other ...


49
Stafford Gary Ashley: Inserter and methods of use. Abbott Diabetes Care, OH Kuni, February 8, 2007: WO/2007/016399 (241 worldwide citation)

Method and apparatus for providing a housing integrated with a sensor introducer and a sensor in analyte monitoring system to deploy the sensor and retain the introducer within the housing upon sensor deployment, and mounting a transmitter to the housing to receive the sensor data is described. The ...


50
Stafford Gary Ashley: Analyte sensor introducer and methods of use. Abbott Diabetes Care, Stafford Gary Ashley, OH Kuni, March 8, 2007: WO/2007/027788 (238 worldwide citation)

Method and apparatus for providing an introducer for transcutaneous placement of at least a portion of an analyte sensor through the skin of a patient is provided.



Click the thumbnails below to visualize the patent trend.